Strengths and weakness of diagnostic tests of SARS CoV-2 infection

doi:10.1016/j.medcli.2020.05.019

. 2020 Nov 27;155(10):464-465.

doi: 10.1016/j.medcli.2020.05.019. Epub 2020 Jun 5.

Strengths and weakness of diagnostic tests of SARS CoV-2 infection

[Article in English, Spanish]

José María Hernández-Pérez¹, Elena Martín-González², María Pino-Yanes³

Affiliations

¹ Servicio de Neumología, Hospital Universitario de N.S. de Candelaria, Santa Cruz de Tenerife, España. Electronic address: jmherper@hotmail.com.
² Grupo de Genómica y Salud, Departamento de Bioquímica, Microbiología, Biología Celular y Genética, Universidad de La Laguna, San Cristóbal de La Laguna, Tenerife, España.
³ Grupo de Genómica y Salud, Departamento de Bioquímica, Microbiología, Biología Celular y Genética, Universidad de La Laguna, San Cristóbal de La Laguna, Tenerife, España; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, España; Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, España.

PMID: 32546315
PMCID: PMC7274578
DOI: 10.1016/j.medcli.2020.05.019

Strengths and weakness of diagnostic tests of SARS CoV-2 infection

[Article in English, Spanish]

José María Hernández-Pérez et al. Med Clin (Barc). 2020.

. 2020 Nov 27;155(10):464-465.

doi: 10.1016/j.medcli.2020.05.019. Epub 2020 Jun 5.

Authors

José María Hernández-Pérez¹, Elena Martín-González², María Pino-Yanes³

Affiliations

¹ Servicio de Neumología, Hospital Universitario de N.S. de Candelaria, Santa Cruz de Tenerife, España. Electronic address: jmherper@hotmail.com.
² Grupo de Genómica y Salud, Departamento de Bioquímica, Microbiología, Biología Celular y Genética, Universidad de La Laguna, San Cristóbal de La Laguna, Tenerife, España.
³ Grupo de Genómica y Salud, Departamento de Bioquímica, Microbiología, Biología Celular y Genética, Universidad de La Laguna, San Cristóbal de La Laguna, Tenerife, España; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, España; Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, España.

PMID: 32546315
PMCID: PMC7274578
DOI: 10.1016/j.medcli.2020.05.019

No abstract available

PubMed Disclaimer

Comment in

Cross-reactions between rheumatoid factor and IgM SARS-CoV-2.
Vinyé Bausà M, Bausà Peris R, Corominas H. Vinyé Bausà M, et al. Med Clin (Barc). 2020 Nov 13;155(9):417-418. doi: 10.1016/j.medcli.2020.07.008. Epub 2020 Jul 28. Med Clin (Barc). 2020. PMID: 32778426 Free PMC article. English, Spanish. No abstract available.

Cited by

[Evaluation of the diagnostic test for rapid detection of covid-19 antigen (Panbio Covid rapid test) in primary care].
Cortés Rubio JA, Costa Zamora MP, Canals Aracil M, Pulgar Feio M, Mata Martínez A, Carrasco Munera A. Cortés Rubio JA, et al. Semergen. 2021 Nov-Dec;47(8):508-514. doi: 10.1016/j.semerg.2021.06.001. Epub 2021 Jun 23. Semergen. 2021. PMID: 34531125 Free PMC article. Spanish.
Cross-reactions between rheumatoid factor and IgM SARS-CoV-2.
Vinyé Bausà M, Bausà Peris R, Corominas H. Vinyé Bausà M, et al. Med Clin (Barc). 2020 Nov 13;155(9):417-418. doi: 10.1016/j.medcli.2020.07.008. Epub 2020 Jul 28. Med Clin (Barc). 2020. PMID: 32778426 Free PMC article. English, Spanish. No abstract available.
Cross-reactions between rheumatoid factor and IgM SARS-CoV-2.
Vinyé Bausà M, Bausà Peris R, Corominas H. Vinyé Bausà M, et al. Med Clin (Engl Ed). 2020 Nov 13;155(9):417-418. doi: 10.1016/j.medcle.2020.07.006. Epub 2020 Oct 9. Med Clin (Engl Ed). 2020. PMID: 33072868 Free PMC article. No abstract available.

References

1. Wang D., Hu B., Hu Ch M.D., Zhu F., Liu X., Zhang J. Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan China. JAMA. 2020;323:1061–1069. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed
1. Castro R., Luz P.M., Wakimoto M.D., Veloso V.G., Grinsztejn B., Perazzo H. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil. Braz J Infect Dis. 2020 doi: 10.1016/j.bjid.2020.04.003. - DOI - PMC - PubMed
1. Marson A, Hsu P, Bern C, Whitman J, Hiatt J, Mowery C, et al. COVID-19 Testing Project. [consultado 8 May 2020]. Disponible en: https://covidtestingproject.org/about.html.
1. Padoan A., Cosma Ch., Sciacovelli L., Faggian D., Plebani M. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics. Clin Chem Lab Med. 2020 doi: 10.1515/cclm-2020-0443. - DOI - PubMed
1. Long Q., Liu B., Deng H., Wu G., Deng K., Chen Y. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 doi: 10.1038/s41591-020-0897-1. - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Wang D., Hu B., Hu Ch M.D., Zhu F., Liu X., Zhang J. Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan China. JAMA. 2020;323:1061–1069. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed

[2] Wang D., Hu B., Hu Ch M.D., Zhu F., Liu X., Zhang J. Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan China. JAMA. 2020;323:1061–1069. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed

[3] Castro R., Luz P.M., Wakimoto M.D., Veloso V.G., Grinsztejn B., Perazzo H. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil. Braz J Infect Dis. 2020 doi: 10.1016/j.bjid.2020.04.003. - DOI - PMC - PubMed

[4] Castro R., Luz P.M., Wakimoto M.D., Veloso V.G., Grinsztejn B., Perazzo H. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil. Braz J Infect Dis. 2020 doi: 10.1016/j.bjid.2020.04.003. - DOI - PMC - PubMed

[5] Marson A, Hsu P, Bern C, Whitman J, Hiatt J, Mowery C, et al. COVID-19 Testing Project. [consultado 8 May 2020]. Disponible en: https://covidtestingproject.org/about.html.

[6] Marson A, Hsu P, Bern C, Whitman J, Hiatt J, Mowery C, et al. COVID-19 Testing Project. [consultado 8 May 2020]. Disponible en: https://covidtestingproject.org/about.html.

[7] Padoan A., Cosma Ch., Sciacovelli L., Faggian D., Plebani M. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics. Clin Chem Lab Med. 2020 doi: 10.1515/cclm-2020-0443. - DOI - PubMed

[8] Padoan A., Cosma Ch., Sciacovelli L., Faggian D., Plebani M. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics. Clin Chem Lab Med. 2020 doi: 10.1515/cclm-2020-0443. - DOI - PubMed

[9] Long Q., Liu B., Deng H., Wu G., Deng K., Chen Y. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 doi: 10.1038/s41591-020-0897-1. - DOI - PubMed

[10] Long Q., Liu B., Deng H., Wu G., Deng K., Chen Y. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 doi: 10.1038/s41591-020-0897-1. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Strengths and weakness of diagnostic tests of SARS CoV-2 infection

Affiliations

Strengths and weakness of diagnostic tests of SARS CoV-2 infection

Authors

Affiliations

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous